He explained that the purpose of holding the DCVMN
meeting is to jointly combat the spread of infectious diseases that are endemic in many developing countries.
The objective of 13th DCVMN General Meeting refers to the specific purpose of striving to increase availability and to improve the quality of vaccines produced in the developing countries.
Member countries of the DCVMN are Argentina, Bangladesh, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, Republic of China, Republic of Korea, South Africa, Thailand and Vietnam.
During the opening ceremony, Dr Mahendra Suhardono, President of DCVMN
, also emphasized the important role of DCVMs in the global efforts to eradicate poliomyelitis disease by supplying OPV vaccines for immunization programs.
Developing countries that have large populations must be prepared in the face of the emergence of new diseases, therefore DCVMN prioritizes vaccine development, among others, of Pentavalent / Hexavalent Vaccines, Pneumococcal Conjugate, Rotavirus, Typhoid Conjugate, Human Papilloma, Measles / Rubella and Inactivated Polio Vaccines, he added.
The Management of Bio Farma is proud of the re-election of Mahendra Suhardono as the president of DCVMN for a second period, and the firm election of a candidate from the vaccine manufacturing representatives of a wide range of countries, such as Brazil, China, India, South Africa.
Iskandar, President Director of Bio Farma, added, "The Management of Bio Farma is proud of the re-election of Mahendra Suhardono as the president of DCVMN for a second period, and the firm election of a candidate from the vaccine manufacturing representatives of a wide range of countries, such as Brazil, China, India, South Africa.
DCVMN Member Country Information: Argentina, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, People's Republic of China, Republic of Korea, Romania, South Africa, Thailand, Viet Nam, South Korea, Iran
Homma said DCVMN
countries have committed to increasing their efforts to develop vaccines to prevent millions of deaths caused by infectious disease.
Recognizing the industry's needs and supported by the DCVMN
, Vaccine World Summit is slated to bring together a distinguished panel of speakers including representatives from WHO, Indian government regulators, NGOs and some of the industry's top minds to address challenges and explore opportunities.
In total, there are currently 37 vaccine-making manufacturers in the 14 DCVMN
was established in Bandung that year, he revealed, as WHO was concerned about the imbalanced playing field of vaccine production at the time when the developed world held dominance of vaccine production.